Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Research Coverage on Small and Micro-Cap Companies

Equity Bottom-Up

Revelation Biosciences  / Equity Bottom-Up

<ul><li>Revelation Biosciences is a life sciences company whose development of immunologic-based therapies is based on the well-established biology of phosphorylated hexaacyl disaccharide (PHAD) and its effect on the innate immune system.</li><li> The company begins the year with outstanding test results, preparing for an FDA decision, presenting its results before a prestigious group and preparing for commercialization.</li><li>We believe investors should look at the stock now as we approach an inflection point.</li></ul>

Revelation Biosciences is a life sciences company whose development of immunologic-based therapies is based on the well-established biology of phosphorylated hexaacyl disaccharide (PHAD) and its effect on the innate immune system. The company begins the year with outstanding test results, preparing for an FDA decision, presenting its results before a prestigious group and preparing for commercialization.We believe investors should look at the stock now as we approach an inflection point.

REVB: 2026년은 좋은 한 해가 될 것 같습니다